Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice

This publication has 26 references indexed in Scilit:

• Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection
  Vaccine, 2005
• Induction of CD69 expression and Th1 cytokines release from human peripheral blood lymphocytes after in vitro stimulation withAlloiococcus otitidisand three middle ear pathogens
  FEMS Immunology & Medical Microbiology, 2005
• Single Intranasal MucosalMycobacterium bovisBCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary Tuberculosis
  Infection and Immunity, 2004
• Immunotherapy with mycobacterium vaccae in the treatment of tuberculosis
  Frontiers in Bioscience-Landmark, 2004
• Mycobacterium tuberculosisinfection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells
  Cellular Microbiology, 2003
• Immune Response Induced by RecombinantMycobacterium bovisBCG Producing the Cholera Toxin B Subunit
  Infection and Immunity, 2003
• Acholeplasma laidlawii up‐regulates granulysin gene expression via transcription factor activator protein‐1 in a human monocytic cell line, THP‐1
  Immunology, 2001
• An Antimicrobial Activity of Cytolytic T Cells Mediated by Granulysin
  Science, 1998
• The Immune Response in Human Tuberculosis—Implications for Tuberculosis Control
  The Journal of Infectious Diseases, 1997
• Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo
  Nature Biotechnology, 1997